Patient Guide: A Single Arm, Open-Label Phase 1/1b Study of RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects with GPC3+ Unresectable Hepatocellular Carcinoma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTRYZ801-101
Status: 🟢 Enrolling Now
Condition: GPC3+ unresectable Hepatocellular Carcinoma
Phase: PHASE1

Loading interactive enrollment tools...

The full interactive experience will load momentarily